Chemogenomic model identifies synergistic drug combinations robust to the pathogen microenvironment
- PMID: 30596642
- PMCID: PMC6329523
- DOI: 10.1371/journal.pcbi.1006677
Chemogenomic model identifies synergistic drug combinations robust to the pathogen microenvironment
Abstract
Antibiotics need to be effective in diverse environments in vivo. However, the pathogen microenvironment can have a significant impact on antibiotic potency. Further, antibiotics are increasingly used in combinations to combat resistance, yet, the effect of microenvironments on drug-combination efficacy is unknown. To exhaustively explore the impact of diverse microenvironments on drug-combinations, here we develop a computational framework-Metabolism And GENomics-based Tailoring of Antibiotic regimens (MAGENTA). MAGENTA uses chemogenomic profiles of individual drugs and metabolic perturbations to predict synergistic or antagonistic drug-interactions in different microenvironments. We uncovered antibiotic combinations with robust synergy across nine distinct environments against both E. coli and A. baumannii by searching through 2556 drug-combinations of 72 drugs. MAGENTA also accurately predicted the change in efficacy of bacteriostatic and bactericidal drug-combinations during growth in glycerol media, which we confirmed experimentally in both microbes. Our approach identified genes in glycolysis and glyoxylate pathway as top predictors of synergy and antagonism respectively. Our systems approach enables tailoring of antibiotic therapies based on the pathogen microenvironment.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures





Similar articles
-
[Do different interpretative methods used for evaluation of checkerboard synergy test affect the results?].Mikrobiyol Bul. 2012 Jul;46(3):410-20. Mikrobiyol Bul. 2012. PMID: 22951653 Turkish.
-
In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.Ann Lab Med. 2016 Mar;36(2):124-30. doi: 10.3343/alm.2016.36.2.124. Ann Lab Med. 2016. PMID: 26709259 Free PMC article.
-
[Various antibiotic combinations against carbapenem resistant Acinetobacter baumannii infections and in vitro synergy test results (2002-2016)].Mikrobiyol Bul. 2018 Apr;52(2):190-197. doi: 10.5578/mb.61903. Mikrobiyol Bul. 2018. PMID: 29933736 Turkish.
-
Antibiotic combinations: should they be tested?Clin Microbiol Rev. 1988 Apr;1(2):139-56. doi: 10.1128/CMR.1.2.139. Clin Microbiol Rev. 1988. PMID: 3069193 Free PMC article. Review.
-
Computational models, databases and tools for antibiotic combinations.Brief Bioinform. 2022 Sep 20;23(5):bbac309. doi: 10.1093/bib/bbac309. Brief Bioinform. 2022. PMID: 35915052 Review.
Cited by
-
Transcriptomic Signatures Predict Regulators of Drug Synergy and Clinical Regimen Efficacy against Tuberculosis.mBio. 2019 Nov 12;10(6):e02627-19. doi: 10.1128/mBio.02627-19. mBio. 2019. PMID: 31719182 Free PMC article.
-
Systematic measurement of combination-drug landscapes to predict in vivo treatment outcomes for tuberculosis.Cell Syst. 2021 Nov 17;12(11):1046-1063.e7. doi: 10.1016/j.cels.2021.08.004. Epub 2021 Aug 31. Cell Syst. 2021. PMID: 34469743 Free PMC article.
-
Sample-efficient identification of high-dimensional antibiotic synergy with a normalized diagonal sampling design.PLoS Comput Biol. 2022 Jul 18;18(7):e1010311. doi: 10.1371/journal.pcbi.1010311. eCollection 2022 Jul. PLoS Comput Biol. 2022. PMID: 35849634 Free PMC article.
-
A mechanistic neural network model predicts both potency and toxicity of antimicrobial combination therapies.medRxiv [Preprint]. 2025 Mar 20:2025.03.19.25324270. doi: 10.1101/2025.03.19.25324270. medRxiv. 2025. PMID: 40166569 Free PMC article. Preprint.
-
SynergyFinder 2.0: visual analytics of multi-drug combination synergies.Nucleic Acids Res. 2020 Jul 2;48(W1):W488-W493. doi: 10.1093/nar/gkaa216. Nucleic Acids Res. 2020. PMID: 32246720 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical